Quantitative analysis of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol in human plasma using high-performance liquid chromatography

J Chromatogr B Biomed Sci Appl. 1999 Mar 5;724(1):163-71. doi: 10.1016/s0378-4347(98)00571-4.

Abstract

A highly sensitive and precise high-performance liquid chromatography (HPLC) assay was developed and validated for the quantitation of Z-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl) phenoxy]ethanol (FC-1271a) in human plasma. Plasma samples (1.0 ml) containing FC-1271a and internal standard (toremifene citrate; Farestono) were extracted using a 2% 1-butanol, 98% hexane solution with an extraction efficiency of >97%. Samples were reconstituted in methanol, irradiated with high intensity ultraviolet light (254 nm) for 1 min, and injected onto a C18 reverse phase column. Samples were eluted isocratically at a flow-rate of 0.5 ml/min with a mobile phase consisting of 6.5% water and 0.5% triethylamine in methanol. The fluorescence of photochemically activated compounds was detected using a fluorometer set at an excitation wavelength of 266 nm and emission wavelength of 370 nm. Under these assay conditions, standard calibration curves were linear through a concentration range of 10-400 ng/ml. In summary, we have developed and validated an HPLC assay to quantitate FC-1271a in human plasma.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid / methods*
  • Estrogen Antagonists / blood*
  • Estrogen Antagonists / pharmacokinetics
  • Freezing
  • Humans
  • Macaca mulatta
  • Photochemistry
  • Reference Standards
  • Reproducibility of Results
  • Spectrometry, Fluorescence
  • Tamoxifen / analogs & derivatives*
  • Tamoxifen / blood
  • Tamoxifen / pharmacokinetics

Substances

  • Estrogen Antagonists
  • Tamoxifen
  • Ospemifene